DOCSLIB.ORG

CGHS DELHI 2010 RATES S.No

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CGHS DELHI 2010 RATES S.No CGHS DELHI 2010 RATES S.No. Name of Treatment Procedure Rates for Rates for Rates for Super NABH Non- Accredited NABH Hospitals Hospitals Spl.Hospitals OPD 1 Consultation OPD 58 50 240 2 Consultation- for Inpatients 72 63 240 3 Dressings of wounds 58 50 4 Suturing of wounds with local anesthesia 124 108 5 Aspiration Plural Effusion - Diagnostic 193 168 6 Aspiration Plural Effusion - Therapeutic 193 168 7 Abdomil Aspiration - Diagnostic 345 300 8 Abdomil Aspiration - Therapeutic 460 400 9 Pericardial Aspiration 380 330 10 Joints Aspiration 317 276 11 Biopsy Skin 230 200 12 Removal of Stitches 41 36 13 Venesection 124 108 14 Phimosis Under LA 1311 1140 15 Sterl puncture 173 150 16 Injection for Haemorrhoids 414 360 17 Injection for Varicose Veins 414 360 18 Catheterisation 83 72 19 Dilatation of Urethra 575 500 20 Incision & Draige 483 420 21 Intercostal Draige 125 106 22 Peritoneal dialysis 1466 1275 Skin 23 Excision of Moles 345 300 24 Excision of Warts 310 264 25 Excision of Molluscumcontagiosum 130 111 26 Excision of Veneral Warts 160 136 27 Excision of Corns 140 119 28 I/D Injection Keloid of Acne 97 84 29 Chemical Cautery (s) 110 96 Opthalmology 30 Subconjunctival/subtenon’s injections in one eyes 69 60 31 Subconjunctival/subtenon’s injections in both eyes 138 120 32 Pterygium surgeries 86 75 33 Conjunctival peritomy 58 50 34 Conjunctival wound repair or exploration following blunt 115 100 trauma 35 Removal of corneal foreign body 115 100 36 Cauterization of ulcer/subconjunctival injection in one eye 69 60 37 Cauterization of ulcer/subconjunctival injection in both 138 120 eyes 38Corneal grafting—Penetrating keratoplasty 5750 5000 39 Corneal grafting—Lamellar keratoplasty 5750 5000 40 Cyanoacrylate /fibrin glue application for corneal 690 600 perforation 41Bandage contact lenses for corneal perforation 460 400 42 Scleral grafting or conjunctival flap for corneal perforation 2300 2000 43 Keratoconus correction with therapeutic contact lenses 1380 1200 44 UV radiation for cross-linking for keratoconus 2300 2000 45 EDTA for band shaped keratopathy 863 750 46 Arcuate keratotomy for astigmatism 2875 2500 47 Re-suturing (Primary suturing) of corneal wound 1150 1000 48 Penetrating keratoplasty ---- with glaucoma surgery 16100 14000 CGHS DELHI 2010 RATES S.No. Name of Treatment Procedure Rates for Rates for Rates for Super NABH Non- Accredited NABH Hospitals Hospitals Spl.Hospitals 49 Penetrating keratoplasty --- with vitrectomy 12144 10560 50 Penetrating keratoplasty ---- with IOL implantation 3450 3000 51 DALK- Deep anterior lamellar keratoplasty 17250 15000 52 Keratoprosthesis stage I and II 11500 10000 53 DSAEK- Descemet’s stripping automated endothelial 21275 18500 keratoplasty 54 ALTK- Automated lamellar therapeutic keratoplasty 16675 14500 55 Probing and Syringing of lacrimal sac- in one eye 69 60 56 Probing and Syringing of lacrimal sac- in both eye 138 120 57 Dacryocystorhinostomy—Plain 1725 1500 58 Dacryocystorhinostomy—Plain with intubation and/or with 9775 8500 lacrimal implants 59 Dacryocystorhinostomy—conjunctival with implant 9775 8500 60 Caliculoplasty 2300 2000 61 Dacryocystectomy 2875 2500 62 Punctal plugs for dry eyes 575 500 63 Refraction 41 36 64 Indirect ophthalmoscopy 104 90 65 Orthoptic check-up- with synoptophore 44 38 66 Lees’ charting or Hess’ charting 115 100 67 Orthoptic exercises 58 50 68 Pleoptic exercises 58 50 69 Perimetry/field test—Goldman 144 125 70 Perimetry/field test— automated 144 125 71Fluorescein angiography for fundus or iris 1104 960 72 Ultrasound A- Scan 173 150 73 Ultrasound B- Scan 288 250 74 Indocyanin green angiography 920 800 75 Corneal endothelial cell count with specular micropscopy 230 200 76 Corneal topography 331 288 77 Corneal pachymetry 230 200 78 Auto-refraction 35 30 79 Macular function tests 58 50 80 Potential acuity metry 115 100 81 Laser interferometry 230 200 82 OCT- Optical coherence tomography 345 300 83 HRT- Heidelberg’s retil tomogram 173 150 84 GDX--- Nerve fibre layer alyzer 138 120 85 UBM- Ultrasound biomicroscopy 230 200 86 Non Contact tonometry 58 50 87 IOP measurement with schiotz 35 30 88 IOP measurement with applation tonometry 58 50 89 Three mirror examition for reti 58 50 90 90 D lens examition 58 50 91 Gonioscopy 58 50 92 Chalazion incision and curettage in one eye 414 360 93 Chalazion incision and curettage in both eyes 442 384 94 Ptosis surgery with fasanella servat procedure 2300 2000 95 Ptosis surgery with LPS resection 6843 5950 96 Ptosis surgery with Sling surgery 6900 6000 97 Ectropion surgery- one lid 1725 1500 98 Ectropion surgery- both lids 3450 3000 99 Epicanthus correction 2300 2000 100 Cantholysis and canthotomy 575 500 101 Entropion surgery- one lid 1380 1200 102 Entropion surgery- both lids 2760 2400 CGHS DELHI 2010 RATES S.No. Name of Treatment Procedure Rates for Rates for Rates for Super NABH Non- Accredited NABH Hospitals Hospitals Spl.Hospitals 103 Tarsorraphy 700 595 104 Suturing of lid lacerations 1150 1000 105 Lid retraction repair 1725 1500 106 Concretions removal 115 100 107 Bucket handle procedure for lid tumors 345 300 108 Cheek rotation flap for lid tumors 6900 6000 109 Orbitotomy 8050 7000 110 Enucleation 3450 3000 111 Enucleation with orbital implants and artificial prosthesis 3450 3000 112 Evisceration 3450 3000 113 Evisceration with orbital implants and artificial prosthesis 5693 4950 114 Telecanthus correction 5175 4500 115 Orbital decompression 5750 5000 116 Exenteration 6900 6000 117 Exenteration with skin grafting 5750 5000 118 Fracture orbital repair 9200 8000 119 Retil laser procedures 1668 1450 120 Retil detachment surgery 11500 10000 121 Retil detachment surgery with scleral buckling 13800 12000 122 Buckle removal 1150 1000 123 Silicone oil removal 2875 2500 124 Anterior retil cryopexy 1162 1010 125 Squint correction for one eye 700 595 126 Squint correction for both eyes 1400 1190 127 Trabeculectomy 6900 6000 128 Trabeculotomy 6900 6000 129 Trabeculectomy with Trabeculotomy 2300 2000 130 Trephition 2300 2000 131 Goniotomy 345 300 132Glaucoma surgery with Glaucoma valves 2300 2000 133 Cyclocryotherapy 1150 1000 134 YAG laser iridotomy 1725 1500 135 YAG laser capsulotomy 1093 950 136 ALT-Argon laser trabeculoplasty 1725 1500 137 PDT-Photodymic therapy 3450 3000 138 TTT- Transpupillary thermal therapy 3450 3000 139 PTK- Phototherapeutic keratectomy 8050 7000 140 Argon/diode laser for reti 1150 1000 141 Intralase application for keratoconus 5750 5000 142 EOG- electro-oculogram 920 800 143 ERG- Electrio-retinogram 794 690 144 VEP- visually evoked potential 920 800 145 Vitrectomy- pars pla 5750 5000 146 Intravitreal injections- of antibiotics 1150 1000 147 Intravitreal injections- of avastin 3450 3000 148 Intravitreal injections- of lucentis 3450 3000 149 X- Ray orbit 115 100 150 CT-orbit and brain 173 150 151 MRI- Orbit and brain 3450 3000 152 Dacryocystography 340 289 153 Orbital angio-graphical studies 1500 1500 154 ECCE with IOL 5750 5000 155 SICS with IOL 840 714 156 Phaco with foldable IOL (silicone and acrylic)/PMMA IOL 10781 9375 CGHS DELHI 2010 RATES S.No. Name of Treatment Procedure Rates for Rates for Rates for Super NABH Non- Accredited NABH Hospitals Hospitals Spl.Hospitals 157 Pars pla lensectomy with/without IOL 11500 10000 158 Secondary IOL implantation- AC IOL PC IOL or scleral 6900 6000 fixated IOL 159 Cataract extraction with IOL with capsular tension rings 13800 12000 (Cionni’s ring) 160 Optic nerve sheathotomy 11500 10000 161 Iridodialysis repair or papillary reconstruction 5693 4950 162 Iris cyst removal 863 750 163 Lid Abscess incision and draige 1725 1500 164 Orbital Abscess incision and draige 3220 2800 165 Biopsy 460 400 166 Paracentesis 230 200 167 Scleral graft for scleral melting or perforation 2875 2500 168 Amniotic membrane grafting 1150 1000 169 Cyclodiathermy 2300 2000 170 Intraocular foreign body removal 187 163 171 Electrolysis 230 200 172 Perforating injury repair 4600 4000 173 Botulinum injection for blepharospasm or squint 2933 2550 Dental Procedures 174 Flap Operation per quadrant 414 360 175 Gingivectomy per quadrant 269 234 176 Reduction & immobilasation of fracture- Maxilla Under LA 1380 1200 177 Reduction & immobilasation of fracture-Mandible Under LA 1725 1500 178 splints/Cirucum mandibular wiring under LA 587 510 179 splints/Cirucum mandibular wiring under GA 1139 990 180 Interl wire fixation/plate fixation of Maxilla under LA 3450 3000 181 Interl wire fixation/plate fixation of Maxilla under GA 4600 4000 182 Interl wire fixation/plate fixation of Mandible under LA 4600 4000 183 Interl wire fixation/plate fixation of Mandible under GA 5750 5000 184 Extraction per tooth under LA 92 80 185 Complicated Ext. per Tooth under LA 115 100 186 Extraction of impacted tooth under LA 184 160 187 Extraction in mentally retarded/patients with systemic 1105 939 diseases/patient with special needs under short term GA 188 Cyst & tumour of Maxilla /mandible by 281 244 enucleation/excision/marsupalisation upto 4 cms under LA 189 Cyst & tumour of Maxilla/mandible by 467 406 enucleation/excision/marsupalisation size more than 4 cms under LA 190 Cyst & tumour of Maxilla/mandible by 1150 1000 enucleation/excision/marsupalisation size more than 4 cms under GA 191 TM joint ankylosis- under GA 9775 8500 192 Biopsy Intraoral-Soft tissue 430 374 193 Biopsy Intraoral-Bone 430 374 194 Hemi-mandibulectomy with graft 5693 4950 195 Hemi-mandibulectomy without graft 3335 2900 196 Segmental-mandibulectomy with graft 4543 3950 197 Segmental-mandibulectomy without graft 1139 990 198 Maxillectomy- Total
Load more

Recommended publications
  • 16. Questions and Answers
    16. Questions and Answers 1. Which of the following is not associated with esophageal webs? A. Plummer-Vinson syndrome B. Epidermolysis bullosa C. Lupus D. Psoriasis E. Stevens-Johnson syndrome 2. An 11 year old boy complains that occasionally a bite of hotdog “gives mild pressing pain in his chest” and that “it takes a while before he can take another bite.” If it happens again, he discards the hotdog but sometimes he can finish it. The most helpful diagnostic information would come from A. Family history of Schatzki rings B. Eosinophil counts C. UGI D. Time-phased MRI E. Technetium 99 salivagram 3. 12 year old boy previously healthy with one-month history of difficulty swallowing both solid and liquids. He sometimes complains food is getting stuck in his retrosternal area after swallowing. His weight decreased approximately 5% from last year. He denies vomiting, choking, gagging, drooling, pain during swallowing or retrosternal pain. His physical examination is normal. What would be the appropriate next investigation to perform in this patient? A. Upper Endoscopy B. Upper GI contrast study C. Esophageal manometry D. Modified Barium Swallow (MBS) E. Direct laryngoscopy 4. A 12 year old male presents to the ER after a recent episode of emesis. The parents are concerned because undigested food 3 days old was in his vomit. He admits to a sensation of food and liquids “sticking” in his chest for the past 4 months, as he points to the upper middle chest. Parents relate a 10 lb (4.5 Kg) weight loss over the past 3 months.
    [Show full text]
  • Chronic Pancreatitis: What the Clinician Want to Know from Mri
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Magn Reson Manuscript Author Imaging Clin Manuscript Author N Am. Author manuscript; available in PMC 2019 August 01. Published in final edited form as: Magn Reson Imaging Clin N Am. 2018 August ; 26(3): 451–461. doi:10.1016/j.mric.2018.03.012. CHRONIC PANCREATITIS: WHAT THE CLINICIAN WANT TO KNOW FROM MRI TEMEL TIRKES, M.D. Department of Radiology and Clinical Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA Keywords Pancreas; Chronic Pancreatitis; Magnetic Resonance Imaging; Magnetic Resonance Cholangiopancreatography; Computerized Tomography INTRODUCTION Chronic pancreatitis (CP) is a low prevalence disease.1–3 In 2006, there were approximately 50 cases of definite CP per 100,000 population in Olmsted County, MN 3, translating to a total of 150,000–200,000 cases in the US population. Clinical features of CP are highly variable and include minimal, or no symptoms of debilitating pain repeated episodes of acute pancreatitis, pancreatic exocrine and endocrine insufficiency and pancreatic cancer. CP profoundly affects the quality of life, which can be worse than other chronic conditions and cancers.4 Natural history studies for CP originated mainly from centers outside the U.S.5−910,11 conducted during the 1960–1990’s and consisted primarily of males with alcoholic CP. Only one large retrospective longitudinal cohort study has been conducted in the US for patients seen at the Mayo Clinic from 1976–1982.12 While these data provide general insights into disease evolution, it is difficult to predict the probability of outcomes or disease progression in individual patients.
    [Show full text]
  • Navigating Home Care: Parenteral Nutrition—Part Two
    NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #11 Series Editor: Carol Rees Parrish, M.S., R.D., CNSD Navigating Home Care: Parenteral Nutrition—Part Two by Gisela Barnadas Parenteral nutrition (PN) is often used for patients who are unable to absorb suffi- cient nutrition through the gastrointestinal tract. PN can be safely administered in the home setting with proper assessment and monitoring of the patient. An interdiscipli- nary team approach is used to identify and avoid potential complications, which may occur. This article provides the physician with specific guidelines for evaluating, ordering and monitoring PN therapy in the home patient. It also addresses financial and reimbursement considerations with emphasis on understanding the often con- fusing, Medicare guidelines. CASE 1 • What resources are available to help manage this JR is a 65-year-old female with vascular disease, patient in the home? hypertension, diabetes and history of a hysterectomy. • What resources are there available for the patient? She presents with severe abdominal pain, vomiting and • Will insurance pay for this? diarrhea. A small bowel series documents a bowel obstruction, most likely due to bowel ischemia. Find- Providing total parenteral nutrition in the home ings during surgical intervention included: twisted, (HPN) is by no means a new treatment option. The gangrenous small bowel with multiple adhesions first record of a patient receiving HPN was a 36-year- resulting in resection of her distal jejunum, ileum and old woman with extensive metastatic ovarian carci- right colon, leaving an intact duodenum, approximately noma in 1968.(1) While the exact number of people 100 cm of the jejunum and most of her left colon.
    [Show full text]
  • P:\DMERC Publications\2004\SUMMER 2004
    DMERC Dialogue Durable Medical Equipment Regional Carrier (DMERC) Region D July 2004 (Summer) General Release 04-3 A Medicare Newsletter for Region D DMEPOS Suppliers - A service of CIGNA HealthCare Medicare Administration Subscribe to the CIGNA Medicare Electronic Mailing List From the Medical Director… To receive automatic notification Robert Hoover, Jr., MD, MPH via e-mail of the posting of LMRPs, publications and other important BAM!!! Let’s Take It Up A Notch Medicare announcements, subscribe to the CIGNA Medicare electronic mailing list at www.cignamedicare.com/mailer/subscribe.asp. By now most of you are familiar with the Comprehen- sive Error Rate Testing (CERT) program from previous articles in the DMERC Dialogue. CERT is the Centers In This Issue for Medicare & Medicaid Services (CMS) initiative that measures claim payment errors in the Medicare pro- FROM THE MEDICAL DIRECTOR gram. BAM!!! Let’s Take It Up A Notch ........................................... 1 MEDICAL POLICY Through oversight audits by the CERT contractor, Durable Medical Equipment: AdvanceMed, contractors like CIGNA Medicare receive Wheelchair Options/Accessories And Wheelchair data on various types of claim errors and use this data Seating - Policy Revisions ............................................ 3 to develop strategies to reduce errors in the Medicare General: program. LMRP Conversion To LCD And Policy Articles .................. 3 Orthotics: Clarification - Coding Of Night Splints For Plantar One of the major types of error is lack of documenta- Fasciitis ........................................................................ 3 tion. Although suppliers who have claims chosen for Pharmacy: CERT review are informed in their notification letter of External Infusion Pumps - Coverage For Gallium the importance of submitting documentation to Nitrate Added ................................................................ 4 AdvanceMed, there is still an unacceptably high non- New Immunosuppressive Drug .........................................
    [Show full text]
  • Meducate® Order Form
    Meducate® Order Form GI Patient Education Brochures and Dietary Booklets Indicate the quantity of each title you would like to order, fill in the total amounts and complete the Ship To, Bill To and Method of Payment sections on the reverse side of this form. Email to [email protected] or fax to (717) 761-0216. 50 brochures per pack. 3 pack minimum. Price per pack: $23.50 GI Patient Education Brochures GI Patient Education Brochures Title English Qty Spanish Qty Title English Qty Spanish Qty Anal Fissure, Abscess, & Fistula MGI-38 ____ MSGI-38 ____ Helicobacter Pylori MGI-30 ____ MSGI-30 ____ Barrett’s Esophagus MGI-40 ____ MSGI-40 ____ Hemorrhoids MGI-10 ____ MSGI-10 ____ Celiac Disease MGI-50 ____ MSGI-50 ____ Hepatitis C MGI-42 ____ MSGI-42 ____ Cirrhosis MGI-14 ____ MSGI-14 ____ Hiatal Hernia MGI-08 ____ MSGI-08 ____ Colonoscopy MGI-19 ____ MSGI-19 ____ High Fiber Diet MGI-22 ____ MSGI-22 ____ Colon Polyps/Cancer MGI-01 ____ MSGI-01 ____ Irritable Bowel Syndrome MGI-03 ____ MSGI-03 ____ Constipation MGI-07 ____ MSGI-07 ____ Lactose Intolerance MGI-24 ____ MSGI-24 ____ Crohn’s Disease MGI-16 ____ MSGI-16 ____ Liver Biopsy MGI-27 ____ MSGI-27 ____ Diarrhea MGI-28 ____ MSGI-28 ____ Low Fiber Low Residue MGI-56 ____ MSGI-56 ____ Diverticulosis/Diverticulitis MGI-02 ____ MSGI-02 ____ Peptic Ulcer Disease MGI-09 ____ MSGI-09 ____ Endoscopic Ultrasound MGI-52 ____ MSGI-52 ____ Prev.
    [Show full text]
  • Post-Whipple: a Practical Approach to Nutrition Management
    NINFLAMMATORYUTRITION ISSUES BOWEL IN GASTROENTEROLO DISEASE: A PRACTICALGY, SERIES APPROACH, #108 SERIES #73 Carol Rees Parrish, M.S., R.D., Series Editor Post-Whipple: A Practical Approach to Nutrition Management Nora Decher Amy Berry The classic pancreatoduodenectomy (PD), also known as the Kausch-Whipple, and the pylorus- preserving pancreatoduodenectomy (PPPD) are most commonly performed for treatment of pancreatic cancer and chronic pancreatitis. This highly complex surgery disrupts the coordination of tightly orchestrated digestive processes. This, in combination with a diseased gland, sets the patient up for nutritional complications such as altered motility (gastroparesis and dumping), pancreatic insufficiency, diabetes mellitus, nutritional deficiencies and bacterial overgrowth. Close monitoring and attention to these issues will help the clinician optimize nutritional status and help prevent potentially devastating complications. 63-year-old female, D.D., presented to the copper, zinc, selenium, and potentially thiamine University of Virginia Health System (UVAHS) (thiamine was repleted before serum levels were Awith weight loss and biliary obstruction. She was checked). A percutaneous endoscopic gastrostomy with diagnosed with a large pancreatic serous cystadenoma jejunal extension (PEG-J) was placed due to intolerance and underwent a pancreatoduodenectomy (PD) of gastric enteral nutrition (EN). After several more (standard Whipple procedure with partial gastrectomy) hospitalizations, prolonged rehabilitation in a nursing with posterior anastomosis and cholecystectomy. Seven home, 7 months of supplemental nocturnal EN, and months later she was admitted to UVAHS with nausea, treatment of pancreatic insufficiency with pancreatic vomiting, diarrhea and a severe weight loss of 47lbs enzymes (with her meals and EN), D.D. was able to (33% of her usual body weight).
    [Show full text]
  • In the Clinic
    in the clinic Irritable Bowel Syndrome Diagnosis page ITC7-2 Treatment page ITC7-8 Practice Improvement page ITC7-14 Patient Information Page page ITC7-15 CME Questions page ITC7-16 Section Editors The content of In the Clinic is drawn from the clinical information and Christine Laine, MD, MPH education resources of the American College of Physicians (ACP), including David Goldmann, MD PIER (Physicians’ Information and Education Resource) and MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine Science Writer editors develop In the Clinic from these primary sources in collaboration with Jennifer F. Wilson the ACP’s Medical Education and Publishing Division and with the assistance of science writers and physician writers. Editorial consultants from PIER and MKSAP provide expert review of the content. Readers who are interested in these primary resources for more detail can consult http://pier.acponline.org and other resources referenced in each issue of In the Clinic. The information contained herein should never be used as a substitute for clinical judgment. © 2007 American College of Physicians Downloaded From: http://annals.org/ by McGill University, Teresa Rudkin on 04/08/2016 in the clinic rritable bowel syndrome (IBS) is a common but poorly understood dis- order that interferes with normal colon function, resulting in abdominal I pain, bloating, constipation, and diarrhea. No specific biological bio- marker, physiologic abnormality, or anatomical defect has been discovered. Psychosocial stress may exacerbate symptoms. IBS is 1 of 28 adult and 17 pediatric functional gastrointestinal disorders. These disorders are symptom-based and not explained by other pathologically defined diseases.
    [Show full text]
  • The Current State of Diagnosis and Management of Chronic Pancreatitis
    DOI: https://doi.org/10.22516/25007440.301 Review articles The current state of diagnosis and management of chronic pancreatitis Lázaro Antonio Arango M., MD1*; Claudia Patricia Díaz T., MD2; Carlos Andrés Caicedo Q., MD3; Camilo Ángel Rodríguez, MD4 1. Physician, General Surgeon, Surgical Clinical Abstract Gastroenterologist, and Coordinator of the Surgical Clinical Gastroenterology Program at the Universidad Chronic pancreatitis (CP) is an inflammatory condition that leads to fibrosis, damage, and even destruction of de Caldas in Manizales, Colombia the pancreatic parenchyma and ducts. These permanent changes can alter pancreatic exocrine and endocri- 2. Physician, General Surgeon, Surgical Clinical ne functioning, cause biliary and pancreatic stenosis, lead to formation of pseudocysts and even increase the Gastroenterologist and Professor of Surgical Clinical Gastroenterology at the Universidad de Caldas in possibility of developing pancreatic cancer. The main clinical characteristic is pain which significantly alters Manizales, Colombia quality of life. To diagnose the CP, we have direct and indirect functional tests and the pancreatic structure test. 3. Physician, General Surgeon and Clinical The great challenge of these methods is early diagnosis, but this is difficult due to the subtlety of changes. Gastroenterologist at the Universidad de Caldas in Manizales, Colombia Once CP is diagnosed, management must be staggered. Medical management is the initial step which can be 4. General Practitioner from the Universidad de los followed by endoscopic management, surgical management, and for the most difficult cases a combination Andes in Bogotá, Colombia of these. The goal is to manage and understand the whole patient and illness to provide the best possible *Correspondence: Lázaro Antonio Arango, quality of life.
    [Show full text]
  • A Primer on Exocrine Pancreatic Insufficiency, Fat Malabsorption, and Fatty Acid Abnormalities
    7/22/2019 Print | AJMC https://www.ajmc.com/journals/supplement/2017/perspectives-in-exocrine-pancreatic-insufficiency/a-primer-on- exocrine-pancreatic-insufficiency-fat-malabsorption-and-fatty-acid-abnormalities-article A Primer on Exocrine Pancreatic Insufficiency, Fat Malabsorption, and Fatty Acid Abnormalities Samer Alkaade, MD and Ashley A. Vareedayah, MD Normal Pancreatic Physiology Positioned next to the duodenum and behind the stomach, the pancreas is an essential part of the gastrointestinal system.1 The location of the pancreas and its unique cellular organization facilitate its physiological role in the digestion and absorption of nutrients. The pancreas is composed of exocrine and endocrine glands; the exocrine portion accounts for roughly 85% of the total volume of the pancreas, whereas the endocrine pancreas represents less than 2%. The remaining pancreatic mass is accounted for by extracellular matrix (10%) and ductal cells and blood vessels (4%).2 The exocrine pancreas is composed of acinar cell clusters and epithelial cells which line pancreatic ducts (ductal cells). The pancreatic acini produce and secrete digestive enzymes which are delivered to the duodenum and along with bile salts are responsible for the majority of the digestive process within the small intestine. Ductal cells produce large quantities of an alkaline mixture of water and bicarbonate, which guides enzyme transport through the pancreatic ducts for delivery to the duodenum, as well as providing the optimum pH for enzyme activity. Clusters of endocrine
    [Show full text]
  • Small Bowel and Liver/Small Bowel Transplantation in Children
    ---------... --.. Small Bowel and Liver/Small Bowel Transplantation in Children By Jorge Reyes, Andreas G. Tzakis, Sat~ru Todo, Bakr Nour, and Thomas E. Starzl Pittsburgh, Pennsylvania A clinical trial of intestinal transplantation was initiated at from either graft rejection, sepsis, or technical failure, the University of Pittsburgh in May 1990. Eleven children with loss of graft and, many times, of the patient. received either a combined liver / small bowel graft (n = 8) or Until 1990, there were only two survivors of isolated an isolated small bowel graft (n = 3). Induction as well as maintenance immunosuppression was with FK-506 and ste­ cadaveric grafts, one in France and the other in roids. Four patients were male, and seven were female; the Germany.6,7 age range was 6 months to 10.2 years. There were 3 deaths A trial of small bowel transplantation alone or with (all in recipients of the combined liver/small bowel graft). the liver was initiated at the University of Pittsburgh which were attributed to graft-versus-host disease (n = 1), in 1990 in both adults and children.s The longest­ posttransplant Iymphoproliferative disease (n = 1), and bili­ ary leak (n = 1). Transplantation of the intestine has evolved surviving child of this series, the recipient of a into a feasible operation, with an overall patient and graft combined liver-intestinal graft more than 2 years survival rate of 73%. These survivors are free of total ago, 8 has enjoyed a normal life-style free of TPN for parenteral nutrition, and the majority are home. These encour­ essentially all of her posttransplant life.9 Although aging results justify further clinical trials.
    [Show full text]
  • Relationship Between Portal HTN and Cirrhosis As a Cause for Diabetes
    Case Report Relationship between portal HTN and cirrhosis as a cause for diabetes Herbert Djiambou-Nganjeu Danylo Halytsky Lviv National Medical University, Lviv, Ukraine ABSTRACT Our aim was to explore the relationship between liver cirrhosis (LC), portal hypertension (PH), and diabetes mellitus (DM). LC displayed hemodynamic alterations reflected by signs and symptoms of hypertension and hyperdynamic circulation. Portal hypertension also caused splenomegaly because of the blood flow into the spleen from the portal vessels and portal flow. The alcoholic cirrhosis displayed abnormal values (AST, ALT, AST/ALT, albumin, ammonia, bilirubin, blood platelet, erythrocytes, glucose, Hb, international normalized ratio (INR), PT, prothrombin index (PI), thymol test, white blood cell (WBC) count), which demonstrated the presence of portal hypertension, ascites, DM, infection, and coagulopathy. The evaluation of liver enzymes and other laboratories data helped to determine the severity of the condition and prognosis. Diabetes appeared to be less affecting the prognosis of patients with cirrhosis than LC itself, showing that hepatocellular failure was largely responsible for patients’ mortality rather than diabetes and its complications. Patients displayed a BMI correlating obesity, although affected by concomitant diseases that commonly cause a severe weight loss. The elevated BMI in this case was accentuated by the presence of ascitic fluid, which is responsible for the increase in weight and the inaccurate BMI evaluation. Ascites affect patients’ recovery from liver diseases. Obese patients with cirrhosis can be related to have a large amount of ascites and that physicians should be expecting to notice changes in their BMI pre- and postoperatively, subsequently making a prior classification as obese inappropriate.
    [Show full text]
  • Pediatric Medical Nutrition Therapy
    SECTION V Pediatric Medical Nutrition Therapy CHAPTER 12 Gastrointestinal Disorders ................... 267 CHAPTER 13 Critical Care. 313 CHAPTER 14 Cardiology ................................ 325 CHAPTER 15 Pulmonary Diseases ........................ 351 CHAPTER 16 Oncology and Hematology ................... 387 CHAPTER 17 Pediatric Surgical Nutrition: Principles and Techniques ............................ 423 CHAPTER 18 Chronic Kidney Disease ...................... 435 CHAPTER 19 Nutrition for Burned Pediatric Patients ......... 449 CHAPTER 20 Diabetes .................................. 465 © Gajus/istock/Getty Images. 265 © Gajus/istock/Getty Images. CHAPTER 12 Gastrointestinal Disorders Jennifer Autodore, Julia Driggers, and Rebecca Wilhelm LEARNING OBJECTIVES ■ Explain how to assess, diagnose, and manage common pediatric gastrointestinal nutrition related topics such as celiac disease, lactose intolerance, inflammatory bowel disease, and pancreatitis ■ Discuss normal digestion and absorption in the gastrointestinal tract ■ Identify diagnosis related at-risk macro and micronutrients ■ Interpret common diagnostic tests for pediatric gastrointestinal disorders particularly vulnerable to disease or surgical resection. ▸ Introduction FIGURE 12.1 graphically portrays the principal sites of The gastrointestinal tract is an organ system that absorption of macro- and micronutrients, vitamins, stretches from the mouth to the anus. It is a large and minerals. muscular tube designed to ingest, digest, and absorb Symptoms of gastrointestinal
    [Show full text]